Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,770.00
+70.00 (1.04%)
At close: Oct 2, 2025

Vivozon Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
326,531339,731144,635149,085186,048296,774
Upgrade
Market Cap Growth
90.88%134.89%-2.99%-19.87%-37.31%18.74%
Upgrade
Enterprise Value
358,549367,642174,909188,576192,882339,521
Upgrade
Last Close Price
6590.006880.003000.003185.005475.0010550.00
Upgrade
PS Ratio
3.923.882.032.893.236.81
Upgrade
PB Ratio
3.293.191.391.442.152.66
Upgrade
P/TBV Ratio
3.433.321.461.522.434.76
Upgrade
P/FCF Ratio
-----79.03
Upgrade
P/OCF Ratio
196.9059.2848.35--64.17
Upgrade
EV/Sales Ratio
4.314.202.453.663.357.79
Upgrade
EV/EBITDA Ratio
-208.4522.04---
Upgrade
EV/EBIT Ratio
--37.14---
Upgrade
EV/FCF Ratio
-112.84----90.41
Upgrade
Debt / Equity Ratio
0.400.340.400.580.970.97
Upgrade
Debt / EBITDA Ratio
-20.705.24---
Upgrade
Debt / FCF Ratio
-----28.87
Upgrade
Asset Turnover
0.480.490.400.270.260.21
Upgrade
Inventory Turnover
2.192.593.312.212.624.67
Upgrade
Quick Ratio
0.110.140.270.450.870.92
Upgrade
Current Ratio
0.510.620.700.601.081.06
Upgrade
Return on Equity (ROE)
-16.57%-10.13%-2.13%-28.26%-71.69%-39.98%
Upgrade
Return on Assets (ROA)
-2.90%-0.63%1.63%-3.21%-5.54%-2.43%
Upgrade
Return on Capital (ROIC)
-3.59%-0.78%1.90%-3.67%-6.28%-2.71%
Upgrade
Return on Capital Employed (ROCE)
--4.30%---
Upgrade
Earnings Yield
-5.04%-2.94%-2.32%-26.77%-37.33%-14.74%
Upgrade
FCF Yield
-0.97%-0.80%-1.06%-6.58%-14.84%1.26%
Upgrade
Buyback Yield / Dilution
-2.56%-0.06%-9.69%-33.41%-24.52%-24.63%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.